1036 GMT October 18, 2021
|
An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
|
|
|
National Desk
|
|
|
National Desk
|
|
www.iran-daily.com
All Content by IRAN DAILY is licensed under a Creative Commons Attribution 4.0 International License.
